首页|期刊导航|中国中西医结合急救杂志|多黏菌素B导致大鼠肾毒性的机制研究

多黏菌素B导致大鼠肾毒性的机制研究OA

Mechanism underlying polymyxin B-induced nephrotoxicity in rats

中文摘要英文摘要

目的 探讨多黏菌素B(PMB)导致大鼠肾损伤的机制.方法 ① 细胞实验:取对数生长期肾间质细胞系(NRK)-52E,将细胞按处理方式不同分为空白对照组、不同剂量[低剂量(200 μmol/L)、中剂量(500 μmol/L)、高剂量(1 000 μmol/L)组]PMB组、PMB+过表达阴性对照(oe-NC)组(PMB+oe-NC组)、PMB+过表达核因子E2 相关因子 2(oe-Nrf2)组(PMB+oe-Nrf2 组).空白对照组不给予药物及转染干预;PMB各剂量组给予相应浓度PMB干预 48 h;PMB+oe-NC组、PMB+oe-Nrf2 组先分别转染阴性对照载体、Nrf2 过表达载体,转染 24 h后加入 1 000 μmol/L PMB继续干预 48 h.各组均设置 3 个复孔,独立重复实验 3 次.采用细胞增殖与毒性检测试剂盒 8(CCK-8)检测细胞增殖活性;采用流式细胞术检测细胞凋亡情况;采用 2',7'-二氯荧光素二乙酸酯(DCFH-DA)荧光探针测定活性氧(ROS)活性;采用蛋白免疫印迹试验(Western blotting)检测细胞中Nrf2、小泛素样修饰蛋白(SUMO1)的蛋白表达水平;采用免疫共沉淀法检测SUMO1 修饰的Nrf2 的蛋白表达水平.② 动物实验:选择 40 只雄性SD大鼠,按随机数字表法分为正常对照组(腹腔注射 0.9%生理盐水溶液)、PMB低剂量组(腹腔注射 9.3 mg/kg PMB,每日 2 次)、PMB中剂量组(腹腔注射 14.0 mg/kg PMB,每日 2 次)和PMB高剂量组(腹腔注射 18.7 mg/kg PMB,每日 2 次),每组 10 只.采用酶联免疫吸附试验(ELISA)测定血尿素氮(BUN)和血清肌酐(SCr)水平,同时测定大鼠肾功能指数;采用苏木素-伊红(HE)染色检测各组大鼠肾组织病理学损伤情况;采用Western blotting检测大鼠肾组织中Nrf2 和SUMO1 的蛋白表达水平.结果 ① 细胞实验:与空白对照组比较,PMB能剂量依赖性地抑制NRK-52E细胞增殖,诱导细胞凋亡,增加ROS水平,抑制Nrf2、SUMO1和SUMO1修饰的Nrf2的蛋白表达水平,以PMB高剂量组与空白对照组相比的变化更明显[细胞增殖活性(A值):0.35±0.03 比 0.98±0.09,细胞凋亡率(%):51.87±7.59 比 8.52±1.08,ROS活性(荧光强度):52.35±6.84 比 17.37±2.14,Nrf2 蛋白表达(Nrf2/β-actin):0.32±0.04 比 0.84±0.07,SUMO1蛋白表达(SUMO1/β-actin):0.54±0.06 比 1.33±0.12,SUMO1 修饰的Nrf2 蛋白表达(SUMO1-Nrf2/β-actin):0.93±0.11 比 2.35±0.34,均P<0.05].与PMB+oe-NC比较,PMB+oe-Nrf2 组细胞增殖活性明显提高,细胞凋亡率和ROS活性明显降低[细胞增殖活性(A值):0.68±0.09 比 0.34±0.07,细胞凋亡率(%):18.34±5.22比 37.75±6.53,ROS活性(荧光强度):38.44±6.31 比 50.79±8.25,均P<0.05].② 动物实验:与正常对照组比较,PMB能增加大鼠血清BUN、SCr水平和肾功能指数,抑制Nrf2、SUMO1 的蛋白表达水平,以PMB高剂量组与正常对照组相比的变化更明显[BUN(mmol/L):13.24±1.25 比 7.89±1.02,SCr(μmol/L):797.37±121.11比 464.98±86.63,肾功能指数(g/100 g):1.87±0.15 比 1.45±0.08,Nrf2 蛋白表达(Nrf2/β-actin):0.31±0.04比 0.83±0.06,SUMO1 蛋白表达(SUMO1/β-actin):0.59±0.06 比 1.24±0.16,均P<0.05].HE染色结果显示PMB能诱导大鼠肾组织病理学损伤.结论 PMB通过抑制SUMO1 修饰的Nrf2 进而加重大鼠肾毒性.

Objective To investigate the mechanism of polymyxin B(PMB)-induced kidney injury in rats.Methods ① Cell experiment:Renal interstitial cell line normal rat kidney cell(NRK)-52E in logarithmic growth phase was divided into blank control group,different doses of PMB groups[low-dose(200 μmol/L),medium-dose(500 μmol/L),high-dose(1 000 μmol/L)group],PMB+overexpression negative control(PMB+oe-NC group),and PMB+overexpression-nuclear factor erythroid 2-related factor 2(Nrf2)group(PMB+oe-Nrf2 group)according to different treatments.The blank control group received no drug or transfection intervention;PMB groups were treated with corresponding concentrations of PMB for 48 h;PMB+oe-NC group and PMB+oe-Nrf2 group were transfected with negative control vector and Nrf2 overexpression vector for 24 hours,respectively,followed by intervention with 1 000 μmol/L PMB for additional 48 hours.Three replicate wells were set in each group,and the independent experiments were repeated 3 times.Cell counting kit-8(CCK-8)was used to detect cell proliferation activity,cell apoptosis was detected by flow cytometry,and 2',7'-dichlorodihydrofluorescein diacetate(DCFH-DA)fluorescent probe method was used to detect intracellular reactive oxygen species(ROS)levels;Western blotting was used to detect the protein expression levels of Nrf2,small ubiquitin-like modifier 1(SUMO1);co-immunoprecipitation was used to detect the protein expression level of SUMOylated Nrf2.② Animal experiment:forty male Sprague-Dawley(SD)rats were randomly divided into normal control group(intraperitoneal injection of 0.9%normal saline),PMB low-dose group(intraperitoneal injection of 9.3 mg/kg PMB,twice daily),PMB medium-dose group(intraperitoneal injection of 14.0 mg/kg PMB,twice daily),and PMB high-dose group(intraperitoneal injection of 18.7 mg/kg PMB,twice daily),with 10 rats in each group.Enzyme-linked immunosorbent assay(ELISA)was used to determine blood urea nitrogen(BUN)and serum creatinine(SCr)levels,and renal function index was calculated;hematoxylin-eosin(HE)staining was used to observe the pathological damage;Western blotting was used to detect the protein expression levels of Nrf2 and SUMO1 in rat kidney tissues.Results ① Cell experiment:compared with the blank control group,PMB inhibited NRK-52E cell viability,induced cell apoptosis,and increased ROS levels,and decreased the protein expression levels of Nrf2,SUMO1 and SUMO1-modified Nrf2 in a dose-dependent manner.The changes were more significant in the PMB high-dose group compared to the blank control group[cell viability(A value):0.35±0.03 vs.0.98±0.09,cell apoptosis rate(%):51.87±7.59 vs.8.52±1.08,ROS activity(fluorescence intensity):52.35±6.84 vs.17.37±2.14,Nrf2 protein expression(Nrf2/β-actin):0.32±0.04 vs.0.84±0.07,SUMO1 protein expression(SUMO1/β-actin):0.54±0.06 vs.1.33±0.12;SUMO1-modified Nrf2 protein expression(SUMO1-Nrf2/β-actin):0.93±0.11 vs.2.35±0.34;all P<0.05].Compared with the PMB+oe-NC group,the PMB+oe-Nrf2 group presented increased cell viability,decreased apoptosis rate and ROS activity[cell proliferation(A value):0.68±0.09 vs.0.34±0.07,apoptosis rate(%):18.34±5.22 vs.37.75±6.53,ROS activity(fluorescence intensity):38.44±6.31 vs.50.79±8.25;all P<0.05].② Animal experiment:compared with the normal control group,PMB significantly elevated BUN,SCr levels,and renal function index,and decreased the protein expression levels of Nrf2 and SUMO1 in rats.The changes were more significant in the PMB high-dose group compared to the control group[BUN(mmol/L):13.24±1.25 vs.7.89±1.02,SCr(μmol/L):797.37±121.11 vs.464.98±86.63,renal function index(g/100 g):1.87±0.15 vs.1.45±0.08,Nrf2 protein expression(Nrf2/β-actin):0.31±0.04 vs.0.83±0.06,SUMO1 protein expression(SUMO1/β-actin):0.59±0.06 vs.1.24±0.16;all P<0.05].HE staining results showed that PMB induced obvious pathological injury of rat kidney tissue.Conclusion PMB aggravates nephrotoxicity in rats by inhibiting SUMO1-modified Nrf2.

王晴;郭丽艳;冯庆国;侯晓明;薛娜

天津市第五中心医院重症医学科,天津 300450||天津市第五中心医院 急诊医学研究所,天津 300450天津市第五中心医院重症医学科,天津 300450||天津市第五中心医院 急诊医学研究所,天津 300450天津市第五中心医院重症医学科,天津 300450||天津市第五中心医院 急诊医学研究所,天津 300450天津市第五中心医院重症医学科,天津 300450||天津市第五中心医院 急诊医学研究所,天津 300450天津市第五中心医院 中心实验室,天津 300450||天津市第五中心医院 天津市早产儿器官发育表观遗传重点实验室,天津 300450

多黏菌素B肾毒性核因子E2 相关因子 2小泛素样修饰蛋白 1

Polymyxin BNephrotoxicityNuclear factor erythroid 2-related factor 2Small ubiquitin-like modifier 1

《中国中西医结合急救杂志》 2026 (3)

320-325,6

国家临床重点专科急诊医学科建设项目(2023283)天津市滨海新区卫生健康委科技项目(2022BWKQ002)天津市医学重点学科(TJYXZDXK-3-003D)National Key Clinical Specialty Construction Project of Emergency Medicine(2023283)Tianjin Binhai New Area Health Commission Science and Technology Project(2022BWKQ002)Tianjin Municipal Key Medical Discipline Construction Project(TJYXZDXK-3-003D)

10.3969/j.issn.1008-9691.2026.03.010

评论